Improving the outcome of neonatal meningitis

被引:22
作者
Galiza, Eva P. [1 ]
Heath, Paul T. [1 ,2 ]
机构
[1] St Georges Univ London, Vaccine Inst, London SW17 0QT, England
[2] St Georges Univ London, Div Child Hlth, London SW17 0QT, England
关键词
antibiotic therapy; healthcare delivery; neonatal meningitis; vaccines; B STREPTOCOCCAL DISEASE; ACUTE BACTERIAL-MENINGITIS; CASE-FATALITY RATE; MENINGOCOCCAL DISEASE; CEREBROSPINAL-FLUID; PARENTERAL PENICILLIN; ANTIBIOTIC-TREATMENT; CARE; CHILDREN; DEXAMETHASONE;
D O I
10.1097/QCO.0b013e32832ad49e
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Neonatal meningitis is an important cause of mortality and morbidity worldwide, and although mortality has declined in developed countries over the last two decades, improvement in morbidity has been less evident. This review focuses on recent advances in the management of neonatal meningitis and its implications for improved outcomes. Recent findings Recent surveillance studies of neonatal meningitis have provided important information regarding the pathogens causing meningitis, their antibiotic-susceptibility profiles and their outcomes. Data supporting the importance of early recognition of the signs of neonatal meningitis, the early diagnosis of the causative pathogen, early and aggressive fluid therapy and supportive care and on the effect of adjunctive therapies on outcome measures are all largely theoretical or derived from paediatric and adult sepsis studies. Summary There is likely to be considerable scope for improving the outcome from neonatal meningitis but more studies are required to define key interventions and to demonstrate their effectiveness.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 49 条
  • [11] Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland
    Fernando, Andrew Michael Russell
    Heath, Paul Trafford
    Menson, Esse Natasha
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 743 - 745
  • [12] Neonatal meningitis: What is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?
    Garges, HP
    Moody, MA
    Cotten, CM
    Smith, PB
    Tiffany, KF
    Lenfestey, R
    Li, JS
    Fowler, VG
    Benjamin, DK
    [J]. PEDIATRICS, 2006, 117 (04) : 1094 - 1100
  • [13] Quality of in-hospital care for adults with acute bacterial meningitis: a national retrospective survey
    Gjini, A. B.
    Stuart, J. M.
    Cartwright, K.
    Cohen, J.
    Jacobs, M.
    Nichols, T.
    Ninis, N.
    Prempeh, H.
    Whitehouse, A.
    Heyderman, R. S.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (11) : 761 - 769
  • [14] Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review
    Hahne, Susan J. M.
    Charlett, Andre
    Purcell, Bernadette
    Samuelsson, Susanne
    Camaroni, Ivonne
    Ehrhard, Ingrid
    Heuberger, Sigrid
    Santamaria, Maria
    Stuart, James M.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7553): : 1299 - 1301
  • [15] Neonatal group B streptococcal disease: Incidence, presentation, and mortality
    Hamada, Sudqi
    Vearncombe, Mary
    Mcgeer, Allison
    Shah, Prakesh S.
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2008, 21 (01) : 53 - 57
  • [16] Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome
    Han, YY
    Carcillo, JA
    Dragotta, MA
    Bills, DM
    Watson, RS
    Westerman, ME
    Orr, RA
    [J]. PEDIATRICS, 2003, 112 (04) : 793 - 799
  • [17] Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study
    Harnden, A
    Ninis, N
    Thompson, M
    Perera, R
    Levin, M
    Mant, D
    Mayon-White, R
    [J]. BRITISH MEDICAL JOURNAL, 2006, 332 (7553): : 1295 - 1297
  • [18] Perinatal group B streptococcal disease
    Heath, Paul T.
    Schuchat, Anne
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2007, 21 (03) : 411 - 424
  • [19] Group B streptococcal disease in UK and Irish infants younger than 90 days
    Heath, PGT
    Balfour, G
    Weisner, AM
    Efstratiou, A
    Lamagni, TL
    Tighe, H
    O'Connell, LAF
    Cafferkey, M
    Verlander, NQ
    Nicoll, A
    McCartney, AC
    [J]. LANCET, 2004, 363 (9405) : 292 - 294
  • [20] Vaccination against Group B streptococcus
    Heath, PT
    Feldman, RG
    [J]. EXPERT REVIEW OF VACCINES, 2005, 4 (02) : 207 - 218